Home > Internet > Grab The Scoop On Vasopressin Receptor Before You're Too Late

Grab The Scoop On Vasopressin Receptor Before You're Too Late

Added: (Sun Jul 16 2017)

Pressbox (Press Release) - 7?and?8 As a consequence, there remains a lack of consensus regarding the most effective strategy for diagnosis and treatment of PES. The objective of this study was to systematically categorize the published English-language literature on PES, collate the evidence, and determine if evidence-based guidelines for Vasopressin Receptor management could be formulated. A systematic review of PES was performed by electronically searching the medical literature published from 1947 to December 2010 using EMBASE Classic, EMBASE, Ovid-MEDLINE, Ovid-MEDLINE in-process and other nonindexed citations, AMED, CINAHL, the Cochrane Database of Systematic Reviews, the Cochrane Database of Controlled Trials, and Elsevier's ScienceDirect catalog. The search strategy was limited to English-language Erlotinib molecular weight articles and used the following terms: ��popliteal�� adj/adj2/adj3 ��entrapment�� and ��popliteal�� adj/adj2/adj3 ��compression�� in titles and abstract fields for all databases. In addition for EMBASE and MEDLINE, the exploded term ��popliteal�� was combined with the keywords ��entrapment�� and ��compression��. Inclusion criteria for articles were prospective studies and retrospective case series with more than five patients. We excluded case reports, case series with fewer than five patients, letters, review articles, and commentaries. The electronic search results were manually reviewed to retrieve relevant titles and complemented by hand searches of reference lists of the included articles. The literature review conformed to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement standards.9 Articles that met the inclusion criteria were further classified according to GSK126 clinical trial the pathology described (ie, entrapment of artery, vein, and/or nerve), and two authors (S.S., R.H.) independently abstracted the data. Data were collected on patient demographics (age, sex), disease presentation (symptoms, laterality), diagnostic adjuncts, type of treatment, duration of follow-up, and outcome measures and summarized in evidence tables as a study-by-study narrative. Outcome measures of interest were mortality rates, complication rates (eg, graft failure and amputations), successful relief of symptoms in operated-on symptomatic limbs, successful prevention of symptoms in operated-on asymptomatic limbs, and results for conservatively managed limbs. Study quality was assessed by examining risk of bias using validated Cochrane methodology.10 The quality of the study was based on the risks of bias and was translated into a level of evidence according to the Scottish Intercollegiate Guidelines Network (SIGN) instrument.11 Owing to the inconsistency of reporting and heterogeneity of study interventions, follow-up, and outcomes��particularly at the patient level��results were not pooled. Statistical analysis was performed using StatsDirect 2.7.8 software (StatsDirect, Cheshire, UK). The Mann-Whitney two-sided U test was used to compare means, with P <.

Submitted by:
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.co.uk together with the url of the release.